Prognostic biomarkers for esophageal adenocarcinoma identified by analysis of tumor transcriptome.
Despite many attempts to establish pre-treatment prognostic markers to understand the clinical biology of esophageal adenocarcinoma (EAC), validated clinical biomarkers or parameters remain elusive. We generated and analyzed tumor transcriptome to develop a practical biomarker prognostic signature i...
Main Authors: | Soo Mi Kim, Yun-Yong Park, Eun Sung Park, Jae Yong Cho, Julie G Izzo, Di Zhang, Sang-Bae Kim, Jeffrey H Lee, Manoop S Bhutani, Stephen G Swisher, Xifeng Wu, Kevin R Coombes, Dipen Maru, Kenneth K Wang, Navtej S Buttar, Jaffer A Ajani, Ju-Seog Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-11-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2994829?pdf=render |
Similar Items
-
Targeting Hippo coactivator YAP1 through BET bromodomain inhibition in esophageal adenocarcinoma
by: Shumei Song, et al.
Published: (2020-06-01) -
Recent advances in preoperative management of esophageal adenocarcinoma [version 1; referees: 2 approved]
by: Kazuto Harada, et al.
Published: (2017-04-01) -
LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma
by: Yan Xu, et al.
Published: (2019-10-01) -
Correction to: LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma
by: Yan Xu, et al.
Published: (2021-03-01) -
A novel patient-derived orthotopic xenograft model of esophageal adenocarcinoma provides a platform for translational discoveries
by: Omkara Lakshmi Veeranki, et al.
Published: (2019-12-01)